U.S. Physical Therapy stock reports 8.5 percent revenue growth

U.S. Physical Therapy stock is backed by second-quarter revenue of USD 214.1 million, an 8.5 percent year-over-year increase in Q2 2026. The company also appointed Myra Davis to its board effective October 1, 2026, according to Business Wire.

Revenue growth meets weaker earnings

According to Quartr, Q2 2026 revenue rose from the year-earlier period to USD 214.1 million, while net income attributable to shareholders fell to USD 9.9 million from USD 12.4 million in Q2 2025. Earnings per share came in at USD 0.25, compared with USD 0.58 a year earlier.

The contrast matters for investors. Revenue growth reflects higher activity, but the lower profit and EPS show that additional volume did not translate into stronger quarterly earnings. The company generated USD 34.37 million in operating cash flow during Q2 2026.

Board change starts October 1

Myra Davis will join the board on October 1, 2026. Business Wire described U.S. Physical Therapy as an operator of outpatient physical therapy clinics and industrial injury prevention services, with 799 clinics in 45 states.

The leadership change arrives after Nchacha Etta became executive vice president and chief financial officer on September 1, 2026. Together, the appointments put management structure alongside the operational question raised by Q2 results, namely whether revenue expansion can improve earnings conversion.

Stock sits below yearly high

U.S. Physical Therapy stood at USD 82.65 on the NYSE on September 23, 2026, down USD 0.52 or 0.63 percent from the prior close. The price was 11.6 percent below the 52-week high of USD 93.50 and 42.0 percent above the 52-week low of USD 58.19.

The market value was USD 1,257,833,820 on September 23, 2026. The combination of 8.5 percent revenue growth, lower year-over-year profit and a share price below the yearly high gives the stock a measurable operating and valuation checkpoint for the next report.